Tekla Capital Management LLC - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 25 filers reported holding TSCAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$500,000
+19.0%
200,0000.0%0.02%
+25.0%
Q1 2023$420,000
+28.8%
200,0000.0%0.02%
+33.3%
Q4 2022$326,000
-46.6%
200,0000.0%0.01%
-52.0%
Q3 2022$610,000
-3.0%
200,0000.0%0.02%0.0%
Q2 2022$629,000
+12.3%
200,0000.0%0.02%
+25.0%
Q1 2022$560,000
-37.8%
200,0000.0%0.02%
-31.0%
Q4 2021$900,000
-46.0%
200,0000.0%0.03%
-46.3%
Q3 2021$1,668,000200,0000.05%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,612,80033.20%
Lynx1 Capital Management LP 5,224,600$13,374,9768.85%
EcoR1 Capital, LLC 5,000,000$12,800,0000.43%
Deer Management Co. LLC 1,245,505$3,188,4930.39%
Simplify Asset Management Inc. 1,046,916$2,680,1050.31%
BVF INC/IL 2,989,474$7,653,0530.21%
Alphabet Inc. 1,077,080$2,757,3240.18%
DC Investments Management, LLC 35,563$91,0410.11%
Baker Brothers Advisors 2,784,792$7,129,0680.04%
Privium Fund Management (UK) Ltd 15,825$41,4620.03%
View complete list of TSCAN THERAPEUTICS INC shareholders